All the patients in the CVID phenotype cohort included in the analysis had a predominantly antibody deficiency: 24 CVID with an unknown genetic defect, one LRBA deficiency, one IKAROS haploinsufficiency and two patients with thymoma with hypogammaglobulinemia (Good syndrome). This evidence concerns the gene IKZF1 and agammaglobulinemia.